Importantly, subsequent rescue experiments clearly proved that TGFβR2 was a key factor mediating the oncogenic roles of Pontin in GBM cells since its restoration effectively restored TGFβ/SMAD signalling, as well as GBM malignancy both in vitro and in vivo. Here, RUVBL1 is linked to glioblastoma.